Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.

Cachexia syndrome consists of adipose and muscle loss, often despite normal food intake. We hypothesized that cachexia-associated adipose wasting is driven in part by tumor humoral factors that induce adipocyte lipolysis. We developed an assay to purify secreted factors from a cachexia-inducing colon cancer line that increases lipolysis in adipocytes and identified leukemia inhibitory factor (LIF) by mass spectrometry. Recombinant LIF induced lipolysis in vitro. Peripheral LIF administered to mice caused >50% loss of adipose tissue and >10% reduction in body weight despite only transient hypophagia due to decreasing leptin. LIF-injected mice lacking leptin (ob/ob) resulted in persistent hypophagia and loss of adipose tissue and body weight. LIF's peripheral role of initiating lipolysis in adipose loss was confirmed in pair-fed ob/ob mouse studies. Our studies demonstrate that (a) LIF is a tumor-secreted factor that promotes cachexia-like adipose loss when administered peripherally, (b) LIF directly induces adipocyte lipolysis, (c) LIF has the ability to sustain adipose and body weight loss through an equal combination of peripheral and central contributions, and (d) LIF's central effect is counterbalanced by decreased leptin signaling, providing insight into cachexia's wasting, despite normophagia.

[1]  Berthold Koletzko,et al.  Towards a multidisciplinary approach to understand and manage obesity and related diseases. , 2017, Clinical nutrition.

[2]  S. Rose-John,et al.  IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling. , 2017, Cell reports.

[3]  Jose M Garcia,et al.  Update on Management of Cancer-Related Cachexia , 2017, Current Oncology Reports.

[4]  T. Wadden,et al.  Management of Obesity. , 2016, Journal of Clinical Oncology.

[5]  T. Zimmers,et al.  STAT3 in the systemic inflammation of cancer cachexia. , 2016, Seminars in Cell and Developmental Biology.

[6]  M. Laplante,et al.  DEPTOR in POMC neurons affects liver metabolism but is dispensable for the regulation of energy balance. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  Danielle N. Seto,et al.  A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia* , 2015, The Journal of Biological Chemistry.

[8]  A. Miyajima,et al.  Deficiency of Oncostatin M Receptor β (OSMRβ) Exacerbates High-fat Diet-induced Obesity and Related Metabolic Disorders in Mice* , 2014, The Journal of Biological Chemistry.

[9]  P. Fayers,et al.  Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: Three peas in a pod? – analysis from a multicenter cross sectional study , 2014, Acta oncologica.

[10]  Clemens Diwoky,et al.  Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia , 2011, Science.

[11]  D. Lacey,et al.  Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.

[12]  D. Marks,et al.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. , 2010, Endocrinology.

[13]  K. Fox,et al.  Estimation of Cachexia among Cancer Patients Based on Four Definitions , 2009, Journal of oncology.

[14]  P. Ponikowski,et al.  Cachexia: a new definition. , 2008, Clinical nutrition.

[15]  T. Britton,et al.  Lipolysis—Not inflammation, cell death, or lipogenesis—Is involved in adipose tissue loss in cancer cachexia , 2008, Cancer.

[16]  A. Levine,et al.  p53 regulates maternal reproduction through LIF , 2007, Nature.

[17]  P. Arner,et al.  Mechanism of increased lipolysis in cancer cachexia. , 2007, Cancer research.

[18]  H. Lim,et al.  Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation. , 2006, Reproduction.

[19]  Stanley Heshka,et al.  Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. , 2003, JAMA.

[20]  Alexander S. Banks,et al.  STAT3 signalling is required for leptin regulation of energy balance but not reproduction , 2003, Nature.

[21]  M. Tisdale.  Cachexia in cancer patients , 2002, Nature Reviews Cancer.

[22]  S. Kalra,et al.  Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods , 2002, Peptides.

[23]  W. Alvord,et al.  Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  O. Ukkola.  [Cachexia]. , 2020, Duodecim; laaketieteellinen aikakauskirja.

[25]  S. Melmed,et al.  Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. , 2000, Endocrine reviews.

[26]  Clifford B Saper,et al.  Leptin Differentially Regulates NPY and POMC Neurons Projecting to the Lateral Hypothalamic Area , 1999, Neuron.

[27]  W. Farmerie,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Anorectic Effects of the Cytokine, Ciliary Neurotropic Factor, Are Mediated by Hypothalamic Neuropeptide Y: Comparison with Leptin* , 2022 .

[28]  R. Cortese,et al.  Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Akiyama,et al.  In vivoEffect of Recombinant Human Leukemia Inhibitory Factor in Primates , 1997, Japanese journal of cancer research : Gann.

[30]  J. M. Beals,et al.  Crystal structure of the obese protein Ieptin-E100 , 1997, Nature.

[31]  J. Heath,et al.  Characterization of the Receptor Binding Sites of Human Leukemia Inhibitory Factor and Creation of Antagonists (*) , 1996, The Journal of Biological Chemistry.

[32]  G. Parry,et al.  A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis , 1996 .

[33]  R. Barohn,et al.  A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. , 1996, Annals of neurology.

[34]  M. Miyata,et al.  Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia , 1994, Japanese journal of cancer research : Gann.

[35]  C. Stewart,et al.  Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.

[36]  J. Friedman,et al.  Molecular mapping of the mouse db mutation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Brattain,et al.  Establishment of mouse colonic carcinoma cell lines with different metastatic properties. , 1980, Cancer research.

[38]  F. Schabel,et al.  Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. , 1975, Cancer research.

[39]  D. Steinberg,et al.  EFFECT OF HORMONES ON LIPOLYSIS AND ESTERIFICATION OF FREE FATTY ACIDS DURING INCUBATION OF ADIPOSE TISSUE IN VITRO. , 1963, Journal of lipid research.